Phage-Encoded Virulence Factor, Gp05, Alters Membrane Phospholipids and Reduces Antimicrobial Susceptibility in Methicillin-Resistant Staphylococcus aureus
The Journal of Infectious Diseases · 2025
DOI: 10.1093/infdis/jiae640 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Yi Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Lundquist Institute for Biomedical Innovation, Harbor-University of California, Los Angeles Medical Center, Torrance. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Virulence Factors, Anti-Bacterial Agents, Phospholipids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of endovascular infections. The prophage-encoded protein Gp05 has been identified as a critical virulence factor that contributes to MRSA persistence during vancomycin treatment in an experimental endocarditis model. However, the mechanisms underlying this persistence phenotype remain poorly understood.
Methods
This study investigated the genetic factors contributing to Gp05-associated MRSA persistence utilizing RNA sequencing (RNA-seq) on an isogenic MRSA strain set, including a clinical persistent bacteremia isolate, its chromosomal gp05 deletion mutant, and gp05-complemented strains.
Results
RNA-seq revealed significant downregulation of the GraSR two-component regulatory system and its downstream genes, mprF and dltABCD, in the gp05 deletion mutant compared to the wild-type and gp05-complemented strains. This downregulation led to a substantial shift in membrane phospholipid composition, with an increased phosphatidylglycerol and a corresponding decrease in lysyl-phosphatidylglycerol. These changes resulted in increased susceptibility of the gp05 deletion mutant to human cationic antimicrobial peptide (CAMP) LL-37, neutrophils, and vancomycin. These results were confirmed in an isogenic gp05 overexpression strain set in MRSA JE2 background.
Conclusions
Gp05 modulates MRSA surface phospholipid components and charge, offering new insights into the molecular mechanisms underlying Gp05-mediated persistence in endovascular infections and potential therapeutic targets to combat these infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lundquist Institute for Biomedical Innovation, Harbor-University of California, Los Angeles Medical Center, Torrance.
- Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles.
- School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, New York.
- Department of Microbiology & Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.
- Departments of Medicine and Medical Microbiology/Immunology, University of Wisconsin School of Medicine and Public Health, Madison.
ORCID-Profile: Liang Chen
Förderung
- NIAID NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Li, Y., Mishra, N. N., Chen, L., Manna, A. C., Cheung, A. L., Proctor, R. A., & Xiong, Y. Q. (2025). Phage-Encoded Virulence Factor, Gp05, Alters Membrane Phospholipids and Reduces Antimicrobial Susceptibility in Methicillin-Resistant Staphylococcus aureus. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae640
Vancouver
Li Y, Mishra NN, Chen L, Manna AC, Cheung AL, Proctor RA, et al. Phage-Encoded Virulence Factor, Gp05, Alters Membrane Phospholipids and Reduces Antimicrobial Susceptibility in Methicillin-Resistant Staphylococcus aureus. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiae640
BibTeX
@article{Li2025,
author = {Li, Yi and Mishra, Nagendra N and Chen, Liang and Manna, Adhar C and Cheung, Ambrose L and Proctor, Richard A and Xiong, Yan Q},
title = {Phage-Encoded Virulence Factor, Gp05, Alters Membrane Phospholipids and Reduces Antimicrobial Susceptibility in Methicillin-Resistant Staphylococcus aureus},
journal = {The Journal of Infectious Diseases},
year = {2025},
doi = {10.1093/infdis/jiae640}
}
EUVIMED